ICN Pharmaceuticals: The Costa Mesa health care...
- Share via
ICN Pharmaceuticals: The Costa Mesa health care company said Monday it has acquired the radioimmunoassay division of Becton, Dickinson & Co. in Orangeburg, N.Y., for an undisclosed amount. The division had sales of about $12 million in 1994. ICN said the acquisition, combined with its own radioimmunoassay activities, will result in a $20-million unit. Radioimmunoassay is a way of detecting disease by measuring the level of hormone activity.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
